Skip to main content


2023 Pediatric Neuro-Oncology Research Conference
June 22-24, 2023
Capital Hilton, Washington DC

Register Today!

View the Program!

The SNO 7th Biennial Pediatric Neuro-Oncology Research Conference will be held June 22-24, 2023, in Washington, D.C. at the Capital Hilton. 

Building on the success of our previous pediatric meetings, this biennial conference encourages the sharing of ideas and results, new collaborations and offers attendees a state-of-the-art update in the field of pediatric brain tumor research. The scientific program will offer outstanding keynotes, panel discussions and abstract presentations on a range of timely themes shaping the future of pediatric neuro-oncology. Topics the conference will include developmental origins of pediatric brain tumors, novel approaches in cancer neuroscience, artificial intelligence, and machine learning, focused ultrasound/drug delivery, diversity & inclusion, novel immunotherapeutic findings, clinical trial reports, and single cell approaches to decipher molecular landscapes. Conference participants will also have opportunities to present their work — and to learn about advances made by others — through short oral presentations and scientific posters selected by the abstract review committee.

The embargo for abstracts published in the abstract supplement to SNO official journal Neuro-Oncology will lift on Monday, June 12, 2023.

Who Should Attend
Pediatric neuro-oncologists, medical oncologists, neurosurgeons, radiation oncologists, radiologists, physician/scientists, clinical and laboratory trainees, and allied health professionals.

Learning Objectives
  • Cite the developmental origins of pediatric brain tumors.
  • Summarize the interactions between normal cells of the nervous system and cancer cells.
  • Explain how artificial intelligence and machine learning approaches can leverage big genomic data sets in cancer biology towards improved treatment options for pediatric patients with CNS tumors.
  • Identify new therapeutic delivery options that effectively treat pediatric patients with brain tumors protected by the blood brain barrier.
  • Summarize recent advances in the experimental and clinical approach to the treatment of pediatric patients with brain tumors
  • Identify recent developments and advances in translational and correlative biology and implications for discovery of novel treatments for pediatric patients with brain tumors.
Sunrise Sessions
  • Diversity, Equity, and Inclusion – Co-Chairs: Cassie Kline and Jessica Tsai 
  • Focused Ultrasound – Co-Chairs: Javad Nazarian and Ying Meng
  • Immunology/CAR T Cells – Co-Chairs: Catherine Flores and Siddhartha Mitra 
  • New Approaches to Drug Delivery – Co-Chairs: Joelle Straehla and Praveen Raju
  • Cancer Neuroscience – Co-Chairs: David Gutmann and Michelle Monje
  • Models of Pediatric Brain Tumors – Chair: Marcel Kool
What To Expect
  • Lectures, Q&A sessions, posters and poster discussions 
  • Live activities to earn AMA PRA Category  1 Credit™ and CME Certificate
  • Opportunities to engage with industry and nonprofit partners 
  • Accepted abstracts to be published in SNO's flagship journal Neuro-Oncology
  • Additional Day of Educational Content
  • Expanded Education for Early Career Professionals
  • New Welcome Reception
  • More Networking
  • Special Nonprofit Showcase
Conference Scientific Co-chairs
Mariella Filbin - Dana-Farber Cancer Institute and Boston Children's Hospital 
Eugene Hwang - Children's National Hospital
Lindsay Kilburn - Children's National Hospital

Exhibit and Support Opportunities
This conference presents a unique opportunity to promote your organization to this highly specialized group of interdisciplinary professionals. SNO is pleased to offer a variety of support opportunities with a range of price points to fit most any budget. Click here for the exhibit and support prospectus. For more information on how you can help move the needle in pediatric research and help improve children's outcomes, contact [email protected]